Home > Press > Emergency Filtration Products Names Philip Dascher as CEO
Emergency Filtration Products, Inc. (EFP) (OTCBB: EMFP) today announced that it had named Philip Dascher as its Chief Executive Officer. Douglas K. Beplate will remain President and a director of the Company. Mr. Beplate will continue to direct the company's efforts to obtain FDA approval for its NanoMask products, as well to continue to head EFP's product development.
Emergency Filtration Products Names Philip Dascher as CEO
HENDERSON, NV | Posted on January 30th, 2007
Mr. Dascher is an entrepreneur who founded and built five successful companies in his business career. In 1972, Mr. Dascher founded three apparel companies. Cumulative sales volume exceeded $80 million that was generated by sales to national retailers, department stores and specialty store chains throughout the United States and Europe. Mr. Dascher sold his interest in these companies in 1979.
In 1985, after having left the industry for a number of years, Mr. Dascher founded two apparel companies, Pelle Leather Ltd. and General Clothing Co., Ltd., with offices in New York, Dallas and Milan. Sales volume reached $48 million, selling to national retailers, department stores and specialty store chains in the United States and Italy. Mr. Dascher divested himself of his interests in these companies in 1996, and has been managing his private investment portfolio and working on a variety of consulting assignments since.
"I am pleased that Philip Dascher has joined EFP," said Douglas K. Beplate, President, EFP. "Phil's successful track record as a founder, builder and manager of companies operating in many different countries and in a highly competitive industry is precisely what we need at EFP at this point in our development." Mr. Beplate went on to add, "Besides managing the company on a day-to-day basis, Phil will upgrade the company's systems and controls, as well as implement an effective sales and marketing program designed to create profitable revenue growth."
"I am delighted to have this opportunity to work with EFP and look forward to building the company with substantial market share in a wide array of filtration products," said Philip Dascher, CEO, EFP. "The first order of business will be to finalize FDA approval for our NanoMask products, a necessary prerequisite that I believe will differentiate us from our competitors." Mr. Dascher also said, "As we work through the FDA application process, we will institute the management systems and controls necessary to position this company to gain significant market share for all its filtration products in governmental, institutional, retail and consumer markets."
About Emergency Filtration Products, Inc
EFP is an air filtration products manufacturer whose patented 2H Technology(TM) ( http://emergencyfiltration.com/Technology/2HTechnology.htm ) filter system has produced filtration efficiencies of 'greater than 99.99%' at a particulate size of 0.027 microns. EFP's initial products were developed for the medical market: the Vapor Isolation Valve(TM) ( http://emergencyfiltration.com/Products/VIV.htm ) and RespAide® ( http://emergencyfiltration.com/Products/RespAide.htm ) CPR Isolation Mask used for resuscitation of respiratory/cardiac arrest cases; and 2H Breathing Circuit Filter for ventilators, respirators and anesthesia circuitry. Each has received FDA approval. The Company also markets an Automated External Defibrillator Prep Kit featuring RespAide; and the NanoMask®, ( http://emergencyfiltration.com/Products/NanoMask.htm ) a nanotechnology enhanced environmental mask. In addition to filtration products, the company supplies Superstat®, ( http://emergencyfiltration.com/Products/Superstat.htm ) a modified hemostatic collagen, to the U.S. Military for surgery and extreme wound care.
About the NanoMask®
EFP's nanoparticle-enhanced environmental mask, the NanoMask® relies on the company's core 2H Technology(TM) filtration system, which utilizes a combination of hydrophobic and hydrophilic filters able to capture, isolate and or eradicate bacterial and viral microorganisms with efficiencies of 99.999%.
Safe Harbor Statement
This release may contain statements that are forward looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. EFP does not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. The actual future results of the company could differ significantly from such forward-looking statements. Specifically, approval from the FDA, if attained, may not translate into significant sales of EFP's products. Sales may be dependent on the success of future marketing campaigns, and both the perceived need for EFP's products and the competitive performance of such products in the marketplace.
For more information, please click here
PAN Consultants Ltd.
Philippe Niemetz, 800-477-7570 or 212-344-6464
Copyright © Business Wire
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Harris & Harris Group Notes the Receipt of Proceeds From the Sale of Molecular Imprints' Semiconductor Business to Canon April 22nd, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014
High-Performance, Low-Cost Ultracapacitors Built with Graphene and Carbon Nanotubes: Future devices based on technology could bridge gap between batteries and conventional capacitors in portable electronics and hybrid electric vehicles April 23rd, 2014
Guo Lab Shows Potential of RNA as Heat-resistant Polymer Material for Nanoarchitectures April 23rd, 2014
National Space Society Congratulates SpaceX on the Success of CRS-3 and the First Flight of the Falcon 9R April 22nd, 2014
Cloaked DNA nanodevices survive pilot mission: Successful foray opens door to virus-like DNA nanodevices that could diagnose diseased tissues and manufacture drugs to treat them April 22nd, 2014
'Exotic' material is like a switch when super thin April 18th, 2014
Tiny particles could help verify goods: Chemical engineers hope smartphone-readable microparticles could crack down on counterfeiting April 15th, 2014
Targeting cancer with a triple threat: MIT chemists design nanoparticles that can deliver three cancer drugs at a time April 15th, 2014
Nanobiotix Appoints Thierry Otin as Head of Manufacturing and Supply April 15th, 2014
Industry Veteran Fergus Clarke Joins Picodeon as CEO: Appointment comes as Picodeon prepares for growth April 8th, 2014
Peter B. Littlewood appointed Director of Argonne National Laboratory March 26th, 2014
Global 450 consortium announces new general manager of internal operations: TSMC’s Cheng-Chung Chien Receives Unanimous Support, Brings History of Innovation and Efficiency to Global Consortium of Companies Driving Industry Transition to 450mm Wafer Technology March 26th, 2014